Report #2844903

Received Jun 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: CA
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (1)

Facial paralysis

Symptom narrative

Facial paralysis; This serious case was reported by a consumer via call center representative and described the occurrence of facial paralysis in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced facial paralysis (Verbatim: Facial paralysis) (serious criteria GSK medically significant). The outcome of the facial paralysis was unknown. It was unknown if the reporter considered the facial paralysis to be related to Shingrix. The company considered the facial paralysis to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 09-JUN-2025 The patient's friend reported this case The patient experienced facial paralysis after receiving the Shingrix injection.; Sender's Comments: Facial paralysis is a listed event which is considered related to GSK vaccine Shingrix.